CROSS-PRIMING OF MINOR HISTOCOMPATIBILITY ANTIGEN-SPECIFIC CYTOTOXIC T-CELLS UPON IMMUNIZATION WITH THE HEAT-SHOCK PROTEIN GP96

被引:273
作者
ARNOLD, D [1 ]
FAATH, S [1 ]
RAMMENSEE, HG [1 ]
SCHILD, H [1 ]
机构
[1] DEUTSCH KREBSFORSCHUNGSZENTRUM, TUMORVIRUS IMMUNOL ABT 0620, D-69120 HEIDELBERG, GERMANY
关键词
D O I
10.1084/jem.182.3.885
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination of mice with heat shock proteins isolated from tumor cells induces immunity to subsequent challenge with those tumor cells the heat shock protein was isolated from but not with other tumor cells (Udono, H., and P. K. Srivastava. 1994. J. Immunol. 152:5398-5403). The specificity of this immune response is caused by tumor-derived peptides bound to the heat shock proteins (Udono., H., and P. K. Srivastava. 1993. J. Exp Med. 178:1391-1396). Our experiments show that a single immunization with the heat shock protein gp96 isolated from beta-galactosidase (beta-gal) expressing P815 cells (of DBA/2 origin) induces cytotoxic T lymphocytes (CTLs) specific for beta-gal, in addition to minor H antigens expressed by these cells. CTLs can be induced in mice that are major histocompatibility complex (MHC) identical to the gp96 donor cells (H-2(d)) as well as in mice with a different MHC (H-2(b)). Thus, gp96 is able to induce ''cross priming'' (Matzinger, P., and M. J. Bevan. 1977. Cell. Immunol. 33:92-100), indicating that gp96-associated peptides are not limited to the MHC class I ligands of the gp96 donor cell. Our data confirm the notion that samples of all cellular antigens presentable by MHC class I molecules are represented by peptides associated with gp96 molecules of that cell, even if the fitting MHC molecule is not expressed. In addition, we extend previous reports on the in vivo immunogenicity of peptides associated gp96 molecules to two new groups of antigens, minor H antigens, and proteins expressed in the cytosol.
引用
收藏
页码:885 / 889
页数:5
相关论文
共 22 条
  • [1] THE ENDOPLASMIC RETICULAR HEAT-SHOCK PROTEIN GP96 IS TRANSCRIPTIONALLY UP-REGULATED IN INTERFERON-TREATED CELLS
    ANDERSON, SL
    SHEN, T
    LOU, J
    XING, L
    BLACHERE, NE
    SRIVASTAVA, PK
    RUBIN, BY
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1565 - 1569
  • [2] 2 PUTATIVE SUBUNITS OF A PEPTIDE PUMP ENCODED IN THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II REGION
    BAHRAM, S
    ARNOLD, D
    BRESNAHAN, M
    STROMINGER, JL
    SPIES, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) : 10094 - 10098
  • [3] BEVAN MJ, 1977, J IMMUNOL, V118, P1370
  • [4] HEAT-SHOCK PROTEIN VACCINES AGAINST CANCER
    BLACHERE, NE
    UDONO, H
    JANETZKI, S
    LI, ZH
    HEIKE, M
    SRIVASTAVA, PK
    [J]. JOURNAL OF IMMUNOTHERAPY, 1993, 14 (04) : 352 - 356
  • [5] CLASS-I-RESTRICTED PROCESSING AND PRESENTATION OF EXOGENOUS CELL-ASSOCIATED ANTIGEN INVIVO
    CARBONE, FR
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (02) : 377 - 387
  • [6] DARROW TL, 1989, J IMMUNOL, V142, P3329
  • [7] CELLULAR PEPTIDE COMPOSITION GOVERNED BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES
    FALK, K
    ROTZSCHKE, O
    RAMMENSEE, HG
    [J]. NATURE, 1990, 348 (6298) : 248 - 251
  • [8] ALLELE-SPECIFIC MOTIFS REVEALED BY SEQUENCING OF SELF-PEPTIDES ELUTED FROM MHC MOLECULES
    FALK, K
    ROTZSCHKE, O
    STEVANOVIC, S
    JUNG, G
    RAMMENSEE, HG
    [J]. NATURE, 1991, 351 (6324) : 290 - 296
  • [9] GAVIN MA, 1993, J IMMUNOL, V151, P3971
  • [10] TUMOR REJECTION ANTIGEN GP96/GRP94 IS AN ATPASE - IMPLICATIONS FOR PROTEIN-FOLDING AND ANTIGEN PRESENTATION
    LI, ZH
    SRIVASTAVA, PK
    [J]. EMBO JOURNAL, 1993, 12 (08) : 3143 - 3151